NCT00632008

Soluble Beta-glucan (SBG) as Treatment for Diabetic Foot Ulcers

A Randomised, Double-blind, Placebo-controlled Study to Determine the Efficacy of Soluble Beta-1,3/1,6-glucan in Chronic Foot Ulcers in Diabetes

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 122 (actual)
• Sponsor: Biotec Pharmacon ASA · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine whether the application of soluble beta-glucan (SBG) onto diabetic foot ulcers improves the healing of the ulcers.

Conditions

• Chronic Diabetic Foot Ulcers

Interventions

Type	Name	Description
DRUG	Soluble beta-glucan (SBG)	Topical application of SBG to the wound, at least twice a week until complete healing or for 8 maximum weeks
DRUG	Placebo comparator	Topical application of placebo to wound, at least twice a week until compleate healing or for maximum 8 weeks.

Timeline

• Start date: 2007-03-01
• Primary completion: 2009-08-01
• Completion: 2009-10-01
• First posted: 2008-03-10
• Last updated: 2010-01-26

Locations

11 sites across 1 country: United Kingdom